Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (375 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 18 Feb 2025 – 20 Aug 2026, limited by Axis Nifty500 Momentum 50 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Axis Nifty500 Momentum 50 Index Fund | Nifty 500 |
|---|---|---|
| 18 Feb 2025 | ₹100.00 | ₹100.00 |
| 05 Apr 2025 | ₹97.74 | ₹100.94 |
| 20 May 2025 | ₹110.24 | ₹109.58 |
| 05 Jul 2025 | ₹115.78 | ₹114.32 |
| 20 Aug 2025 | ₹111.64 | ₹112.28 |
| 04 Oct 2025 | ₹109.57 | ₹111.72 |
| 19 Nov 2025 | ₹116.07 | ₹115.99 |
| 04 Jan 2026 | ₹113.40 | ₹116.92 |
| 18 Feb 2026 | ₹112.71 | ₹114.72 |
| 05 Apr 2026 | ₹100.06 | ₹101.59 |
| 21 May 2026 | ₹112.11 | ₹109.66 |
| 05 Jul 2026 | ₹112.63 | ₹113.05 |
| 20 Aug 2026 | ₹116.43 | ₹114.08 |
| Metric | Axis · Direct NAV ₹11.28 Very High risk ★★☆☆☆ 1Y | Category median Index Funds · 375 funds |
|---|---|---|
| +4.29% | +5.66% | |
| — | +8.82% | |
| — | +9.15% | |
| — | +11.72% | |
| +10.67% | +7.67% | |
| +7.05% | — | |
| — | +12.67% | |
| — | +13.64% | |
| — | +12.84% | |
| Risk | ||
| 18.77% | 13.97% | |
| -0.12 | 0.24 | |
| -0.17 | 0.36 | |
| -17.02% | -16.12% | |
| Nifty 500 | — | |
| — | +0.84% | |
| — | 1.00 | |
| — | 102.2% | |
| — | 97.2% | |
| 0.77% | 0.36% | |
| ₹149.56Cr | ₹177.09Cr | |
| 0.25% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| — | 35% | |
| Karthik Kumar | — | |
| 18 Feb 2025 | — | |
| 50 | — | |
| 46.1% | — | |
| -4.8% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.